Перейти к основному содержанию
AkademIndex

Продукты

Для разработчиков

AkademBaseОткрытый API экосистемы
Препринт

Residential radon and lung cancer--detailed results of a collaborative analysis of individual data on 7148 persons with lung cancer and 14,208 persons without lung cancer from 13 epidemiologic studies in Europe.

Sarah DarbyClinical Trial Service Unit and Epidemiological Studies Unit, University of OxfordHill, D.Clinical Trial Service Unit and Epidemiological Studies Unit, University of OxfordH. DeoAnssi AuvinenTampere School of Public HealthJ.M. Barros-DiosUniversidade de Santiago de Compostela [Spain]H. BayssonService de RadioBiologie et d'EpidémiologieF. BochicchioItalian National Institute of HealthRolf FalkSara FarchiRome E Health AuthorityAdolfo FigueirasM HakamaFinnish Cancer RegistryI. HeidForschungszentrum fur Umwelt und GesundheitNezahat HunterLothar KreienbrockMichaela KreuzerBundesamt für Strahlenschutz - Federal Office for Radiation ProtectionLagarde, F.I MäkeläinenSäteilyturvakeskus [Suomi] = Radiation and Nuclear Safety Authority in Finland = Autorité de sûreté nucléaire et de radioprotection [Finlande]C. MuirheadWilhelm OberaignerGöran PershagenE. RuosteenojaSäteilyturvakeskus [Suomi] = Radiation and Nuclear Safety Authority in Finland = Autorité de sûreté nucléaire et de radioprotection [Finlande]Angelika Schaffrath RosarioForschungszentrum fur Umwelt und GesundheitM. TirmarcheService de RadioBiologie et d'EpidémiologieLadislav TomášekNational Radiation Protection InstituteElise WhitleyUniversity of Bristol [Bristol]H.‐Erich WichmannForschungszentrum fur Umwelt und GesundheitRichard DollClinical Trial Service Unit and Epidemiological Studies Unit, University of Oxford
2006en
ABI

Аннотация

OBJECTIVES: Studies seeking direct estimates of the lung cancer risk associated with residential radon exposure lasting several decades have been conducted in many European countries. Individually these studies have not been large enough to assess moderate risks reliably. Therefore data from all 13 European studies of residential radon and lung cancer satisfying certain prespecified criteria have been brought together and analyzed. METHODS: Data were available for 7148 persons with lung cancer and 14,208 controls, all with individual smoking histories and residential radon histories determined by long-term radon gas measurements. RESULTS: The excess relative risk of lung cancer per 100 Bq/m3 increase in the observed radon concentration was 0.08 [95% confidence interval (95% CI) 0.03-0.16; P=0.0007] after control for confounding. The dose-response relationship was linear with no evidence of a threshold, and it remained significant when only persons with observed radon concentrations of <200 Bq/m3 were included. There was no evidence that the excess relative risk varied with age, sex, or smoking history. Removing the bias induced by random uncertainties related to radon exposure assessment increased the excess relative risk of lung cancer to 0.16 (95% CI 0.05-0.31) per 100 Bq/m3. With this correction, estimated risks at 0, 100, and 400 Bq/m3, relative to lifelong nonsmokers with no radon exposure, were 1.0, 1.2, and 1.6 for lifelong nonsmokers and 25.8, 29.9, and 42.3 for continuing smokers of 15-24 cigarettes/day. CONCLUSIONS: These data provide firm evidence that residential radon acts as a cause of lung cancer in the general population. They provide a solid basis for the formulation of policies with which to manage risk from radon and reduce deaths from the most common fatal cancer in Europe.

Перевод пока недоступен

Цитирования и источники

Цитирований: 2Использованных источников: 0